LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 40.44 | 771.67 | 2020 | 4738 | 0.4263 | 0.4442 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 42.67 | 771.67 | 1999 | 5155 | 0.3877 | 0.4153 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 42.67 | 771.67 | 2066 | 5155 | 0.4007 | 0.4325 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 44.89 | 771.67 | 2042 | 5541 | 0.3685 | 0.4080 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 44.89 | 771.67 | 2189 | 5541 | 0.3950 | 0.4428 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 47.11 | 771.67 | 2133 | 5941 | 0.3590 | 0.4124 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 47.11 | 771.67 | 2239 | 5941 | 0.3768 | 0.4358 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 49.33 | 771.67 | 2230 | 6392 | 0.3488 | 0.4161 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 49.33 | 771.67 | 2311 | 6392 | 0.3615 | 0.4327 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 51.55 | 771.67 | 2337 | 6829 | 0.3422 | 0.4223 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 51.55 | 771.67 | 2352 | 6829 | 0.3444 | 0.4251 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 53.77 | 771.67 | 2363 | 7256 | 0.3256 | 0.4136 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 53.77 | 771.67 | 2466 | 7256 | 0.3398 | 0.4324 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 55.99 | 771.67 | 2477 | 7690 | 0.3221 | 0.4213 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 55.99 | 771.67 | 2542 | 7690 | 0.3306 | 0.4325 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 58.21 | 771.67 | 2582 | 8085 | 0.3193 | 0.4281 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 58.21 | 771.67 | 2661 | 8085 | 0.3291 | 0.4409 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 60.44 | 771.67 | 2679 | 8530 | 0.3140 | 0.4320 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 60.44 | 771.67 | 2696 | 8530 | 0.3160 | 0.4346 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 62.66 | 771.67 | 2750 | 8978 | 0.3063 | 0.4318 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 62.66 | 771.67 | 2760 | 8978 | 0.3074 | 0.4333 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 64.88 | 771.67 | 2770 | 9447 | 0.2932 | 0.4243 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 64.88 | 771.67 | 2833 | 9447 | 0.2999 | 0.4332 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 67.10 | 771.67 | 2912 | 9800 | 0.2971 | 0.4365 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 67.10 | 771.67 | 2897 | 9800 | 0.2956 | 0.4344 | MN20160304_L01 | G04 |